Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin 20 vs Mercilon for Contraception
NCT00624130Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial of drospirenone in contraception (2 arms), sponsored by Bayer. Primary endpoint: Cycle control and bleeding pattern. Started Mar 2004; status: completed.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00624130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624130.